BRIEF published on 03/26/2024 at 22:35, 1 year 8 months ago Regents Park Funds to Shut Down Anfield Diversified Alternatives ETF Investment Strategy Liquidation Process Regents Park Funds Anfield Diversified Alternatives ETF ETF Closure
BRIEF published on 03/26/2024 at 22:35, 1 year 8 months ago Regents Park Funds va fermer l'ETF Anfield Diversified Alternatives Stratégie D'investissement Processus De Liquidation Fonds Regents Park FNB Alternatif Diversifié Anfield Clôture Du FNB
PRESS RELEASE published on 03/26/2024 at 22:30, 1 year 8 months ago Notice of Intent to Close the Anfield Diversified Alternatives ETF Regents Park Funds LLC announces the closure of the Anfield Diversified Alternatives ETF (DALT) to investors, outlining key dates and procedures for shareholders Investors Liquidation Anfield Diversified Alternatives ETF Regents Park Funds LLC Closure
Published on 12/05/2025 at 02:35, 4 hours 55 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 30 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 25 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 30 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 29 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 59 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 39 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 4 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 15 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 15 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 30 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 30 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 45 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 45 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
